Preclinical studies for a cationic liposome formulation containing Il-2 Intended for the treatment of Human Tumors
Crossref DOI link: https://doi.org/10.29328/journal.apps.1001010
Published Online: 2018-10-29
Update policy: https://doi.org/10.29328/crossmark-policy
Corona-Ortega, MT
Version of Record valid from 2013-11-25
Accepted Manuscript valid from 2016-04-18